千人·生物  >> Vol. 2 No. 4 (November 2015)

干细胞生物技术专利信息情报初步分析
Preliminary Information Analysis of the Stem Cell Biotechnology Patents

DOI: 10.12677/QRB.2015.24007, PDF, HTML, XML, 下载: 2,199  浏览: 5,787 

作者: 姜铁竹, 刘书朋, 李 苗:上海大学通信与信息工程学院,生物医学工程研究所,上海;张永娟, 陈成材, 陈 恒*:中国科学院上海生命科学信息中心,上海;孙瑞阳*:北京东方灵盾科技有限公司,北京

关键词: 干细胞生物技术专利信息统计情报分析Stem Cell Biotechnological Patent Information Statistics Information Analysis

摘要: 本文主要对国内外干细胞生物技术相关专利进行了有效的检索、收集与分类整理,并进一步对国内外干细胞生物技术相关专利信息进行了统计和深入的情报分析。统计显示,中国在干细胞生物技术专利领域的国际专利申请为830件,而国际专利4260件,国际专利中主要为美国、日本和韩国等国家的专利申请,说明美国、日本和韩国等在干细胞生物技术领域的研究已走在了我国前头,因此,我国必须继续加强干细胞生物技术的研究和相关专利的申请,同时也急需促进干细胞生物技术产业领域的发展。
Abstract: This paper focused on the effective search, collection and classification of domestic and interna-tional stem cell biotechnology patents. Furthermore, deep analysis and statistics of the stem cell biotechnology patents were performed. The results show that the stem cell biotechnology patents in China were about 830 items and the international stem cell biotechnology patents were about 4260 items. American, Japan and South Korea, as several countries with the most number of patents applications, have gone ahead of China in stem cell biotechnology research field. Therefore, China must continue to reinforce the stem cell biotechnology researches and the related patents applications, and also urgently to promote the industrial development of the stem cell biotechnology field simultaneously.

文章引用: 姜铁竹, 刘书朋, 李苗, 张永娟, 陈成材, 孙瑞阳, 陈恒. 干细胞生物技术专利信息情报初步分析[J]. 千人·生物, 2015, 2(4): 53-59. http://dx.doi.org/10.12677/QRB.2015.24007

参考文献

[1] Morales, E.E. and Wingert, R.A. (2014) Renal Stem Cell Reprogramming: Prospects in Regenerative Medicine. World Journal of Stem Cells, 6, 458-466.
http://dx.doi.org/10.4252/wjsc.v6.i4.458
[2] Ishii, T. and Eto, K. (2014) Fetal Stem Cell Transplantation: Past, Present, and Future. World Journal of Stem Cells, 6, 404-420.
http://dx.doi.org/10.4252/wjsc.v6.i4.404
[3] Noiseux, N., Marquis-Gravel, G., Mansour, S., Shahzad, U., Stewart, D.J. and Yau, T.M. (2014) The Current State of Stem Cell Therapeutics: Canadian Approaches in the International Context. Canadian Journal of Cardiology, 30, 1361-1369.
http://dx.doi.org/10.1016/j.cjca.2014.04.031
[4] Xiao, L., Saiki, C. and Ide, R. (2014) Stem Cell Therapy for Central Nerve System Injuries: Glial Cells Hold the Key. Neural Regeneration Research, 9, 1253-1260.
http://dx.doi.org/10.4103/1673-5374.137570
[5] Bensinger, W. (2014) Allogeneic Stem Cell Transplantation for Multiple Myeloma. Hematology/Oncology Clinics of North America, 28, 891-902.
http://dx.doi.org/10.1016/j.hoc.2014.06.001
[6] Matar, A.A. and Chong, J.J. (2014) Stem Cell Therapy for Cardiac Dysfunction. Springerplus, 3, 440.
http://dx.doi.org/10.1186/2193-1801-3-440
[7] 闫舫, 王韫芳, 刘大庆, 袁红丰, 张鹏, 管利东, 师伟, 姚海雷, 杨印祥, 裴雪涛. 干细胞专利现状研究[J]. 中华医学科研管理杂志, 2006, 19(4): 197-200, 242.
[8] Wang, S.J. (2011) The Stem Cell Patent Landscape as Relevant to Cancer Vaccines. Human Vaccines, 7, 1100-1108.
http://dx.doi.org/10.4161/hv.7.10.17022
[9] Quattrocelli, M., Thorrez, L. and Sampaolesi, M. (2013) Pluripotent Stem Cell Derivation and Differentiation toward Cardiac Muscle: Novel Techniques and Advances in Patent Literature. Recent Patents on Drug Delivery and Formulation, 7, 18-28.
http://dx.doi.org/10.2174/187221113804805883